Fort Lauderdale
,
Florida
16 - 18 June 2023
Foundation for Sickle Cell Disease Research (FSCDR 2023)
Presentation schedule and materials
Sunday, 18 June 2023
13:45
- 14:00
EDT
ORAL PRESENTATION
Priority Needs of the US Sickle Cell Community: Insights from US Advisory Boards
Andre Harris1; Biree Andemariam2; Mia Robinson3; Regina Hartfield4; Adam Wufsus5; Caterina Minniti6
15:30
- 15:45
EDT
ORAL PRESENTATION
ASCENT1 : A phase 2 trial to evaluate the efficacy and safety of oral decitabine–tetrahydrouridine (NDec) in patients with sickle cell disease
Biree Andemariam1; Pernille Højlund Nielsen2; Rikke Zillmer2; Julie Derving Karsbøl2
MATERIALS AVAILABLE
16:15
- 16:30
EDT
ORAL PRESENTATION
Hibiscus-Kids: A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease
E. Leila Jerome Clay1; Raffaella Colombatti2; Julie Kanter3; Miguel R. Abboud4; Eric Wu1; Adlette Inati5
Keywords